SBI Capital Markets Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation 13(4), Regulation ....
M&A
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 01 Jun 2026, 07:50 PM IST · BSE ID: c0fdc097-7524-4898-81f2-99d08c4eef9a
View Original BSE Filing (PDF)
💡
In Simple Terms
A company called Anupam Rasayan India is offering to buy 26.00% of Bliss GVS Pharma shares for ₹ 299.00 per share.
🤖 AI Summary
- Anupam Rasayan India Limited issued a Detailed Public Statement for an open offer for Bliss GVS Pharma Limited.
- The open offer is to acquire up to 2,77,26,848 equity shares, representing 26.00% of the company's capital.
- The offer price is ₹ 299.00 per equity share, aggregating up to ₹ 8,29,03,27,552.00 assuming full acceptance.
- SBI Capital Markets Limited is serving as the Manager to the Open Offer for Anupam Rasayan India Limited.
- The Detailed Public Statement was published in The Financial Express, Jansatta, and Navshakti on June 1, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Open Offer Shares
2,77,26,848 Equity Shares
Percentage of Expanded Voting Share Capital
26.00%
Offer Price per Share
₹ 299.00
Total Offer Consideration (assuming full acceptance)
₹ 8,29,03,27,552.00
🏢 How This Affects the Company
The open offer, if fully accepted, represents a potential acquisition value of up to ₹ 8,29,03,27,552.00 for 26.00% of Bliss GVS Pharma's expanded voting share capital.
Public shareholders face the decision of tendering their shares at the offer price of ₹ 299.00 per share, potentially impacting their ownership and future returns.
👥 What This Means For Shareholders
✅
Action Required
Public shareholders of Bliss GVS Pharma Limited must decide whether to tender their shares in the open offer at the price of ₹ 299.00 per share.
👤
Who Is Affected
Public shareholders are affected as Anupam Rasayan India Limited is offering to acquire up to 26.00% of the expanded voting share capital of Bliss GVS Pharma, totaling 2,77,26,848 equity shares.
🔍
Management Signal
The filing indicates a formal progression of a substantial acquisition process, confirming the intent of Anupam Rasayan India Limited to increase its stake in Bliss GVS Pharma.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Open offer tendering period — confirm start and end dates for shareholders.
Open offer outcome — verify final number of shares tendered and accepted.
Future disclosures from Anupam Rasayan India Limited regarding its stake in Bliss GVS Pharma.
MEDIUM RISK
The open offer introduces uncertainty regarding future ownership structure and potential strategic shifts for Bliss GVS Pharma.
💡 Investor Takeaway
Anupam Rasayan India Limited has filed a Detailed Public Statement for an open offer to acquire up to 2,77,26,848 equity shares of Bliss GVS Pharma at ₹ 299.00 per share. The offer represents 26.00% of the expanded voting capital, totaling up to ₹ 8,29,03,27,552.00.
⚖️ Strengths & Concerns
✅ Positives
- The offer provides a clear exit opportunity for public shareholders at a defined price of ₹ 299.00 per equity share.
- The acquisition, if completed, could introduce a significant new shareholder, Anupam Rasayan India Limited, into Bliss GVS Pharma.
⚠️ Concerns
- The filing does not provide details on the strategic rationale or future business plans following the potential acquisition.
- The information available is primarily procedural regarding the open offer disclosure, without financial impact specifics for Bliss GVS Pharma.
❓ Frequently Asked Questions
What is the offer price per share in the open offer for Bliss GVS Pharma?
The offer price for each equity share of Bliss GVS Pharma Limited in the open offer is ₹ 299.00.
How many shares is Anupam Rasayan India Limited offering to acquire in Bliss GVS Pharma?
Anupam Rasayan India Limited is offering to acquire up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma Limited.
What percentage of Bliss GVS Pharma's capital does this open offer represent?
The open offer represents 26.00% of the Expanded Voting Share Capital of Bliss GVS Pharma Limited.
What is the total consideration for the open offer, assuming full acceptance?
The total consideration for the open offer, assuming full acceptance, is up to ₹ 8,29,03,27,552.00.
Questions based on this BSE filing only. For information purposes.